Voxzogo (vosoritide) is a drug approved for the treatment of children with achondroplasia. It has been shown to improve annual growth rate in children with achondroplasia and promote proportional growth.
The multidisciplinary medical team looking after your child will be able to address specific medical concerns and related health issues.
Below are some related medical issues and how they can be managed:
Subscribe to our mailing list to get the updates to your email inbox...